LENZ Therapeutics, Inc. (LENZ)
LENZ Therapeutics, Inc. (LENZ)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -0.017 | -0.012 | -0.009 | -0.007 |
| Net Profit Margin | -2,218.832 | 500 | -132.088 | -299.94 |
| Debt to Asset Ratio | 9.556 | 7.041 | 7.962 | 5.046 |
| Cash Ratio | 95.993 | 118.842 | 155.669 | 361.685 |
| Quick Ratio | 1,026.385 | 1,408.77 | 1,262.859 | NaN |
| Current Ratio | 1,039.94 | 1,422.627 | 1,268.675 | 2,054.26 |